UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 867

Sortiert nach

JAK inhibitors as promising agents for refractory Takayasu arteritis

Annals of the rheumatic diseases, 2022-04, Vol.81 (4), p.e67

Watanabe, Ryu

2022

Link zum Volltext

Verfügbarkeit prüfen

Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study

Rheumatology (Oxford, England), 2020-09, Vol.59 (9), p.e46-e47

Watanabe, Ryu

2020

Link zum Volltext

Verfügbarkeit prüfen

High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis

Journal of bone and mineral metabolism, 2020-09, Vol.38 (5), p.737-738

Watanabe, Ryu

2020

Link zum Volltext

Verfügbarkeit prüfen

Challenging therapeutic goal in large vessel vasculitis

International journal of cardiology, 2019-07, Vol.287, p.120

Watanabe, Ryu

2019

Link zum Volltext

Verfügbarkeit prüfen

Perspectives of JAK Inhibitors for Large Vessel Vasculitis

Frontiers in immunology, 2022-03, Vol.13, p.881705-881705

2022

Link zum Volltext

Verfügbarkeit prüfen

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in Giant Cell Arteritis

Rheumatology (Oxford, England), 2022-07, Vol.61 (7), p.e183-e184

2022

Link zum Volltext

Verfügbarkeit prüfen

Pathogenic role of monocytes/macrophages in large vessel vasculitis

Frontiers in immunology, 2022-07, Vol.13, p.859502-859502

2022

Link zum Volltext

Verfügbarkeit prüfen

Vasculitogenic T Cells in Large Vessel Vasculitis

Frontiers in immunology, 2022-06, Vol.13, p.923582-923582

2022

Link zum Volltext

Verfügbarkeit prüfen

Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders

Frontiers in aging neuroscience, 2022-04, Vol.14, p.843305-843305

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis

Circulation (New York, N.Y.), 2018-05, Vol.137 (18), p.1934-1948

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis

Proceedings of the National Academy of Sciences - PNAS, 2017-02, Vol.114 (6), p.E970-E979

2017

Link zum Volltext

Verfügbarkeit prüfen

The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease

The Journal of experimental medicine, 2016-03, Vol.213 (3), p.337-354

2016

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint dysfunction in large and medium vessel vasculitis

American journal of physiology. Heart and circulatory physiology, 2017-05, Vol.312 (5), p.H1052-H1059

2017

Link zum Volltext

Verfügbarkeit prüfen

Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations

Journal of clinical medicine, 2023-09, Vol.12 (18), p.5996

2023

Link zum Volltext

Verfügbarkeit prüfen

Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study

PloS one, 2024-01, Vol.19 (1), p.e0295048-e0295048

2024

Link zum Volltext

Verfügbarkeit prüfen

Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process

PloS one, 2023-08, Vol.18 (8), p.e0289760-e0289760

2023

Link zum Volltext

Verfügbarkeit prüfen

Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation

Annals of the rheumatic diseases, 2018-07, Vol.77 (7), p.1053

2018

Link zum Volltext

Verfügbarkeit prüfen

Vasculitis associated with VEXAS syndrome: A literature review

Frontiers in medicine, 2022-08, Vol.9, p.983939-983939

2022

Link zum Volltext

Verfügbarkeit prüfen

Better Retention of Abatacept Is Associated with High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients with Rheumatoid Arthritis

The Tohoku Journal of Experimental Medicine, 2020, Vol.250(3), pp.153-159

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis—Similarities and Differences

Current rheumatology reports, 2020-08, Vol.22 (10), p.68-68, Article 68

2020

Link zum Volltext

Verfügbarkeit prüfen

Cytokines, growth factors and proteases in medium and large vessel vasculitis

Clinical immunology (Orlando, Fla.), 2019-09, Vol.206, p.33-41

2019

Link zum Volltext

Verfügbarkeit prüfen

Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5643

2023

Link zum Volltext

Verfügbarkeit prüfen

Cellular Signaling Pathways in Medium and Large Vessel Vasculitis

Frontiers in immunology, 2020-09, Vol.11, p.587089-587089

2020

Link zum Volltext

Verfügbarkeit prüfen

Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort

Arthritis research & therapy, 2024-01, Vol.26 (1), p.16-16, Article 16

2024

Link zum Volltext

Verfügbarkeit prüfen

Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus

Modern rheumatology, 2018-11, Vol.28 (6), p.986-992

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 867

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(593)
Mit Volltextzugriff
(805)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(384)
Life Sciences & Biomedicine
(272)
Humans
(217)
Male
(122)
Female
(112)
Middle Aged
(85)
Aged
(74)
Physical Sciences
(74)
Rheumatology
(64)
Adult
(60)
Physics Of Elementary Particles And Fields
(59)
Technology
(58)
Animals
(52)
Biological And Medical Sciences
(52)
Physics
(46)
Rheumatoid Arthritis
(38)
Medical Sciences
(37)
Medicine
(36)
General & Internal Medicine
(34)
Science & Technology - Other Topics
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

JAK inhibitors as promising agents for refractory Takayasu arteritis

Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study

High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis

Challenging therapeutic goal in large vessel vasculitis

Perspectives of JAK Inhibitors for Large Vessel Vasculitis

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in Giant Cell Arteritis

Pathogenic role of monocytes/macrophages in large vessel vasculitis

Vasculitogenic T Cells in Large Vessel Vasculitis

Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders

Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis

Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis

The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease

Immune checkpoint dysfunction in large and medium vessel vasculitis

Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations

Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study

Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process

Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation

Vasculitis associated with VEXAS syndrome: A literature review

Better Retention of Abatacept Is Associated with High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients with Rheumatoid Arthritis

Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis—Similarities and Differences

Cytokines, growth factors and proteases in medium and large vessel vasculitis

Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update

Cellular Signaling Pathways in Medium and Large Vessel Vasculitis

Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort

Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus

Suchergebnisse filtern